APA (7th ed.) Citation

Palma, D., Kwan, K., Gaede, S., Landis, M., Malthaner, R., Fortin, D., . . . Inculet, R. (2016). A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results. International Journal of Radiation Oncology, Biology, Physics, 96, E473. https://doi.org/10.1016/j.ijrobp.2016.06.1818

Chicago Style (17th ed.) Citation

Palma, D.A, et al. "A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results." International Journal of Radiation Oncology, Biology, Physics 96 (2016): E473. https://doi.org/10.1016/j.ijrobp.2016.06.1818.

MLA (9th ed.) Citation

Palma, D.A, et al. "A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results." International Journal of Radiation Oncology, Biology, Physics, vol. 96, 2016, p. E473, https://doi.org/10.1016/j.ijrobp.2016.06.1818.